Avecho Biotechnology Limited (OEZ) - Total Liabilities

Latest as of December 2025: €5.55 Million EUR ≈ $6.48 Million USD

Based on the latest financial reports, Avecho Biotechnology Limited (OEZ) has total liabilities worth €5.55 Million EUR (≈ $6.48 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Avecho Biotechnology Limited (OEZ) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Avecho Biotechnology Limited - Total Liabilities Trend (2013–2025)

This chart illustrates how Avecho Biotechnology Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Avecho Biotechnology Limited's balance sheet.

Avecho Biotechnology Limited Competitors by Total Liabilities

The table below lists competitors of Avecho Biotechnology Limited ranked by their total liabilities.

Company	Country	Total Liabilities
LakeShore Biopharma Co., Ltd NASDAQ:LSB	USA	$867.91 Million
Handok Clean Tech Co. Ltd KQ:256150	Korea	₩10.17 Billion
Camellia Metal Co Ltd TWO:2064	Taiwan	NT$1.52 Billion
Terranet AB ST:TERRNT-B	Sweden	Skr18.84 Million
MST GOLF GROUP BERHAD KLSE:5316	Malaysia	RM125.56 Million
Union Materials Corp KO:047400	Korea	₩123.97 Billion
Graines Voltz S.A PA:GRVO	France	€91.58 Million
Zuleika Gold Ltd AU:ZAG	Australia	AU$2.06 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Avecho Biotechnology Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Avecho Biotechnology Limited to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	9.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.56	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.78	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Avecho Biotechnology Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Avecho Biotechnology Limited (2013–2025)

The table below shows the annual total liabilities of Avecho Biotechnology Limited from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€5.55 Million ≈ $6.48 Million	+221.15%
2024-12-31	€1.73 Million ≈ $2.02 Million	+83.43%
2023-12-31	€941.54K ≈ $1.10 Million	+2.27%
2022-12-31	€920.66K ≈ $1.08 Million	+29.79%
2021-12-31	€709.36K ≈ $829.32K	+1.31%
2020-12-31	€700.17K ≈ $818.57K	+25.90%
2019-12-31	€556.12K ≈ $650.17K	-38.35%
2018-12-31	€902.04K ≈ $1.05 Million	-50.87%
2017-12-31	€1.84 Million ≈ $2.15 Million	+7.57%
2016-12-31	€1.71 Million ≈ $2.00 Million	-6.00%
2015-12-31	€1.82 Million ≈ $2.12 Million	-3.04%
2014-12-31	€1.87 Million ≈ $2.19 Million	-14.36%
2013-12-31	€2.19 Million ≈ $2.56 Million	--

About Avecho Biotechnology Limited

F:OEZ Germany Biotechnology

Market Cap

$30.12 Million

€25.76 Million EUR

Market Cap Rank

#24372 Global

#2099 in Germany

Share Price

€0.01

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.01

All Time High

€0.03